FDA, HMOs to Analyze Medication Effects on 1 Million U.S. Births
Posted Jan 08 2010 8:27am
WebMD reports, "...the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP)...is a collaboration between the FDA, Kaiser Permanente, Vanderbilt University (using Tennessee Medicaid data), and a consortium of HMOs called the HMO Research Network Center for Education and Research in Therapeutics (managed by Harvard University). The study will analyze health care data on about 1 million U.S. births from 2001 to 2007. The idea is to gather information on all medications prescribed for pregnant women and to look for health effects and birth outcomes."
The study will analyze health care data on about 1 million U.S. births from 2001 to 2007. The idea is to gather information on all medications prescribed for pregnant women and to look for health effects and birth outcomes."